摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-bromo-7-(vinyloxy)naphthalene | 1219691-35-6

中文名称
——
中文别名
——
英文名称
2-bromo-7-(vinyloxy)naphthalene
英文别名
2-(allyloxy)-7-bromonaphthalene;2-bromo-7-prop-2-enoxynaphthalene
2-bromo-7-(vinyloxy)naphthalene化学式
CAS
1219691-35-6
化学式
C13H11BrO
mdl
——
分子量
263.134
InChiKey
MHHPPMOOUGLCFV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.5
  • 重原子数:
    15
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.08
  • 拓扑面积:
    9.2
  • 氢给体数:
    0
  • 氢受体数:
    1

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-bromo-7-(vinyloxy)naphthaleneRuCl2(1,3-dimesityl-imidazolidin-2-yl)(PCy3)(=CHPh) 、 palladium on activated charcoal 、 三氟化硼乙醚氢气 、 sodium hydride 、 magnesium1,2-二溴乙烷N,N-二异丙基乙胺 、 N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate 、 lithium hydroxide 作用下, 以 四氢呋喃甲醇二氯甲烷乙酸乙酯1,2-二氯乙烷N,N-二甲基甲酰胺 、 mineral oil 为溶剂, 反应 10.67h, 生成 (2R,4S,7S)-7-tert-butyl-N-[(1R,2S)-1-(cyclopropylsulfonylcarbamoyl)-2-ethenylcyclopropyl]-2-methoxy-6,9-dioxo-10,16-dioxa-5,8-diazatetracyclo[15.5.3.12,5.020,24]hexacosa-1(23),17(25),18,20(24),21-pentaene-4-carboxamide
    参考文献:
    名称:
    The discovery and optimization of naphthalene-linked P2-P4 Macrocycles as inhibitors of HCV NS3 protease
    摘要:
    Naphthalene-linked P2-P4 macrocycles within a tri-peptide-based acyl sulfonamide chemotype have been synthesized and found to inhibit HCV NS3 proteases representing genotypes 1a and 1b with single digit nanomolar potency. The pharmacokinetic profile of compounds in this series was optimized through structural modifications along the macrocycle tether as well as the P1 subsite. Ultimately a compound with oral bioavailability of 100% in rat, and a long half-life in plasma was obtained. However, compounds in this macrocyclic series exhibited cardiac effects in an isolated rabbit heart model and for this reason further optimization efforts were discontinued. (C) 2017 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2017.11.005
  • 作为产物:
    描述:
    参考文献:
    名称:
    有机催化不对称脱芳构化反应构建轴向手性乌拉唑嵌萘酮
    摘要:
    在本文中,我们公开了β-萘酚与 4-aryl-1,2,4-triazole-3,5-diones的催化不对称脱芳构化反应。发现具有螺基序的手性磷酸对该反应有效。具有轴向和中心手性的手性乌拉唑嵌入萘酮以良好到高产率 (70-85%) 获得,具有高非对映和对映选择性 (>20:1, 8-96% ees),具有 C−N 旋转能垒31.54 K.Cal.mol −1和 t 1/2 25  °C=589.8 年。该反应的范围很广,很少有包括溴胺化反应在内的应用得到证实。
    DOI:
    10.1002/adsc.202300080
点击查看最新优质反应信息

文献信息

  • Hepatitis C Virus Inhibitors
    申请人:Hiebert Sheldon
    公开号:US20100080770A1
    公开(公告)日:2010-04-01
    Hepatitis C virus inhibitors having the general formula are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
    揭示了具有一般式的丙型肝炎病毒抑制剂。还揭示了包含这些化合物的组合物以及使用这些化合物抑制HCV的方法。
  • HEPATITIS C VIRUS INHIBITORS
    申请人:Bristol-Myers Squibb Company
    公开号:EP2331552A1
    公开(公告)日:2011-06-15
  • [EN] HEPATITIS C VIRUS INHIBITORS<br/>[FR] INHIBITEURS DU VIRUS DE L'HÉPATITE C
    申请人:BRISTOL MYERS SQUIBB CO
    公开号:WO2010036551A1
    公开(公告)日:2010-04-01
    Hepatitis C virus inhibitors having the general formula are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
  • The discovery and optimization of naphthalene-linked P2-P4 Macrocycles as inhibitors of HCV NS3 protease
    作者:Michael Bowsher、Sheldon Hiebert、Rongti Li、Alan X. Wang、Jacques Friborg、Fei Yu、Dennis Hernandez、Ying-Kai Wang、Herbert Klei、Ramkumar Rajamani、Kathy Mosure、Jay O. Knipe、Nicholas A. Meanwell、Fiona McPhee、Paul M. Scola
    DOI:10.1016/j.bmcl.2017.11.005
    日期:2018.1
    Naphthalene-linked P2-P4 macrocycles within a tri-peptide-based acyl sulfonamide chemotype have been synthesized and found to inhibit HCV NS3 proteases representing genotypes 1a and 1b with single digit nanomolar potency. The pharmacokinetic profile of compounds in this series was optimized through structural modifications along the macrocycle tether as well as the P1 subsite. Ultimately a compound with oral bioavailability of 100% in rat, and a long half-life in plasma was obtained. However, compounds in this macrocyclic series exhibited cardiac effects in an isolated rabbit heart model and for this reason further optimization efforts were discontinued. (C) 2017 Elsevier Ltd. All rights reserved.
  • Organocatalytic Asymmetric Dearomatization Reaction for the Construction of Axially Chiral Urazole Embedded Naphthalenones
    作者:Subhas Pan、Chandrakanta Parida、Siddharth K. Dave、Kousik Das
    DOI:10.1002/adsc.202300080
    日期:——
    Herein we disclose a catalytic asymmetric dearomatization reaction of β-naphthols with 4-aryl-1,2,4-triazole-3,5-diones. A chiral phosphoric acid with spiro motif was found to be effective for this reaction. The chiral urazole embedded naphthalenones having both axial and central chirality were obtained in good to high yields (70–85%) with high diastereo- and enantioselectivities (>20:1, 8–96% ees)
    在本文中,我们公开了β-萘酚与 4-aryl-1,2,4-triazole-3,5-diones的催化不对称脱芳构化反应。发现具有螺基序的手性磷酸对该反应有效。具有轴向和中心手性的手性乌拉唑嵌入萘酮以良好到高产率 (70-85%) 获得,具有高非对映和对映选择性 (>20:1, 8-96% ees),具有 C−N 旋转能垒31.54 K.Cal.mol −1和 t 1/2 25  °C=589.8 年。该反应的范围很广,很少有包括溴胺化反应在内的应用得到证实。
查看更多